Identification of Predictive Biomarkers for Response to Biologic Therapies in Inflammatory Bowel Disease

Conditions:   Inflammatory Bowel Diseases;   Crohn Disease;   Ulcerative Colitis Intervention:   Biological: Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab Sponsor:   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials